Yali Li1, Ling Wang, Zhihong Liu
1Research Center for Drug Discovery & Institute of Human Virology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. junxu@biochemomes.com.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed machine learning models to identify selective Liver X receptor (LXR) beta agonists for treating dyslipidemia. These models accurately predict compounds that activate LXRβ without activating LXRα, minimizing side effects like lipogenicity.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: